OncoCyte
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
PURA VIDA INVESTMENTS, LLC 10 percent owner
 Common Stock 767,952 $1.33 $1,023,680
Purchase
PURA VIDA INVESTMENTS, LLC 10 percent owner
 Common Stock 57,630 $1.26 $72,614
Purchase
PURA VIDA INVESTMENTS, LLC 10 percent owner
 Common Stock 19,210 $1.23 $23,571
Purchase
PURA VIDA INVESTMENTS, LLC 10 percent owner
 Common Stock 1,916,419 $1.33 $2,554,587
Purchase
PURA VIDA INVESTMENTS, LLC 10 percent owner
 Common Stock 92,370 $1.26 $116,386
Purchase
PURA VIDA INVESTMENTS, LLC 10 percent owner
 Common Stock 30,790 $1.23 $37,779
Purchase
PURA VIDA INVESTMENTS, LLC 10 percent owner
 Common Stock 1,665,898 $1.33 $2,220,642
Purchase
ROSS DOUGLAS T. officer: Chief Scientific Officer
 Common Stock, no par value 15,000 $1.4 $21,000
Purchase
PAULSEN GISELA officer: Chief Operating Officer
 Common Stock, no par value 16,500 $1.2 $19,767
Purchase
ANDREWS RONALD ASBURY director, officer: Chief Execut..
 Common Stock, no par value 50,000 $1.28 $64,150
Purchase
REDMOND CAVAN M. director
 Common Stock, no par value 40,000 $1.19 $47,560
Purchase
LEVINE MITCHELL S officer: Chief Financial Officer
 Common Stock, no par value 25,000 $1.17 $29,150
Option
ANDREWS RONALD ASBURY director, officer: Chief Execut..
 Common Stock, no par value 65,000 N/A N/A
Option
ANDREWS RONALD ASBURY director, officer: Chief Execut..
 Restricted Stock Units 65,000 N/A N/A
Option
ANDREWS RONALD ASBURY director, officer: Chief Execut..
 Common Stock, no par value 106,221 N/A N/A
Option
ANDREWS RONALD ASBURY director, officer: Chief Execut..
 Restricted Stock Units 106,221 N/A N/A
Option
LEVINE MITCHELL S officer: CFO
 Common Shares, no par value 20,000 N/A N/A
Option
LEVINE MITCHELL S officer: CFO
 Restricted Stock Units 20,000 N/A N/A
Purchase
ANDREWS RONALD ASBURY director, officer: Chief Execut..
 Common Stock, no par value 11,000 N/A N/A
Purchase
BROADWOOD PARTNERS, L.P. 10 percent owner
 Common Stock, no par value 600,000 $4.5 $2,700,000
Purchase
BROADWOOD PARTNERS, L.P. 10 percent owner
 Common Stock, no par value 1,460,280 $3.42 $4,999,999
Option
KINGSLEY ALFRED D director
 Common Stock, no par value 65,271 $1.34 $87,463
Option
KINGSLEY ALFRED D director
 Option to purchase common stock 65,271 $1.34 $87,463
Option
KINGSLEY ALFRED D director
 Common Stock, no par value 1,237 $1.34 $1,658
Sale
KINGSLEY ALFRED D director
 Common Stock, no par value 900 $2.55 $2,295
Option
KINGSLEY ALFRED D director
 Option to purchase common stock 1,237 $1.34 $1,658
Option
KINGSLEY ALFRED D director
 Common Stock, no par value 10,516 $1.34 $14,091
Sale
KINGSLEY ALFRED D director
 Common Stock, no par value 7,652 N/A N/A
Option
KINGSLEY ALFRED D director
 Option to purchase common stock 10,516 $1.34 $14,091
Sale
KINGSLEY ALFRED D director
 Common Stock, no par value 35,148 $1.27 $44,638
Option
KINGSLEY ALFRED D director
 Common Stock, no par value 47,976 $1.34 $64,288
Sale
KINGSLEY ALFRED D director
 Common Stock, no par value 35,148 $1.27 $44,638
Option
KINGSLEY ALFRED D director
 Option to purchase common stock 47,976 $1.34 $64,288
Purchase
LEVINE MITCHELL S officer: CFO
 Common Stock 10,000 N/A N/A
Purchase
PARKER ALBERT P officer: COO
 Common Stock, no par value 5,000 $1.33 $6,650
Purchase
KALAJIAN TONY T officer: Sr.VP/Chief Accounting..
 Common Stock, no par value 5,000 N/A N/A
Purchase
LEVINE MITCHELL S officer: CFO
 Common Stock, no par value 10,000 $1.32 $13,200
Purchase
ANDREWS RONALD ASBURY director, officer: Chief Execut..
 Common Stock, no par value 40,000 $1.35 $53,880
Purchase
BROADWOOD PARTNERS, L.P. 10 percent owner
 Common Stock, no par value 1,050,000 $2.27 $2,383,500
Purchase
ANDREWS RONALD ASBURY director, officer: Chief Execut..
 Common Stock, no par value 18,000 $2,372 $42,696,000
Purchase
ANDREWS RONALD ASBURY director, officer: Chief Execut..
 Common Stock, no par value 27,216 $2.26 $61,454
Option
LEVINE MITCHELL S officer: CFO
 Restricted Stock Units 20,000 N/A N/A
Option
LEVINE MITCHELL S officer: CFO
 Common Shares, no par value 20,000 N/A N/A
Purchase
BROADWOOD PARTNERS, L.P. 10 percent owner
 Common Stock, no par value 1,391,466 $2.16 $3,000,001
Sale
LINEAGE CELL THERAPEUTICS, INC. other: Previous 10% Owner
 Common Stock, no par value 2,383,090 $2.16 $5,137,942
Purchase
BROADWOOD PARTNERS, L.P. 10 percent owner
 Common Stock, no par value 1,176,471 N/A N/A
Purchase
ARNO ANDREW director
 Common Stock, no par value 50,000 $2.16 $108,150
Purchase
KALAJIAN TONY T officer: Sr.VP/Chief Accounting..
 Common Stock, no par value 10,000 $1.98 $19,800
Purchase
LEVINE MITCHELL S officer: CFO
 Common Stock, no par value 10,000 $2.01 $20,060
Purchase
LEVINE MITCHELL S officer: CFO
 Common Stock 10,000 $2.01 $20,060

Showing 50 to 100 of 113 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: